Seven Six Capital Management LLC Boosts Stock Holdings in Perrigo Company plc $PRGO

Seven Six Capital Management LLC lifted its holdings in Perrigo Company plc (NYSE:PRGO) by 15.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 382,400 shares of the company’s stock after purchasing an additional 51,600 shares during the period. Perrigo comprises approximately 5.4% of Seven Six Capital Management LLC’s portfolio, making the stock its 8th largest holding. Seven Six Capital Management LLC’s holdings in Perrigo were worth $5,323,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Amundi lifted its position in shares of Perrigo by 11.7% in the 1st quarter. Amundi now owns 5,292 shares of the company’s stock worth $148,000 after buying an additional 556 shares during the last quarter. Kestra Investment Management LLC lifted its position in shares of Perrigo by 57.1% in the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock worth $47,000 after buying an additional 642 shares during the last quarter. Geneos Wealth Management Inc. lifted its position in shares of Perrigo by 439.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock worth $27,000 after buying an additional 786 shares during the last quarter. Jones Financial Companies Lllp lifted its position in shares of Perrigo by 89.1% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,778 shares of the company’s stock worth $38,000 after buying an additional 838 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Perrigo by 116.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock worth $26,000 after buying an additional 1,014 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

PRGO has been the topic of a number of recent research reports. Canaccord Genuity Group reduced their price target on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research report on Friday, February 27th. Weiss Ratings upgraded shares of Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday. Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Jefferies Financial Group reiterated a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Perrigo has a consensus rating of “Hold” and a consensus target price of $19.33.

Perrigo Trading Down 0.4%

Shares of NYSE:PRGO opened at $10.66 on Wednesday. The company has a market cap of $1.47 billion, a PE ratio of -0.81, a P/E/G ratio of 1.27 and a beta of 0.51. The company’s 50-day moving average price is $11.18 and its 200 day moving average price is $12.41. Perrigo Company plc has a fifty-two week low of $9.23 and a fifty-two week high of $28.43. The company has a quick ratio of 1.59, a current ratio of 2.72 and a debt-to-equity ratio of 1.45.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.04. The firm had revenue of $841.80 million for the quarter, compared to the consensus estimate of $1.04 billion. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. Perrigo’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same period last year, the firm posted $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Sell-side analysts anticipate that Perrigo Company plc will post 2.11 earnings per share for the current year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th were given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 10.9%. The ex-dividend date was Friday, May 29th. Perrigo’s payout ratio is -8.85%.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.